Dyspnea increases long-term mortality risk

Individuals with dyspnea, or shortness of breath, have an increased long-term mortality risk compared with individuals without dyspnea, according to a new study presented at the 2014 American Thoracic Society International Conference.

"Dyspnea may be an indicator of serious underlying disease," said lead author Gene Pesola, MD, MPH, of Columbia University in New York. "In our study of nearly 12,000 individuals who were followed for up to 12 years, we found that those who had at baseline had a greater risk of dying, even after adjusting our analyses for other for mortality, including smoking."

The population-based study included 11,746 subjects who were recruited between 2000 and 2002 in rural Bangladesh. During 12 years of follow-up, there were 782 deaths. Before adjustment for other possible risk factors, subjects with dyspnea at baseline had a 2.73-fold increased risk of dying compared with those without dyspnea at baseline.

After adjustment for age, gender, education, (BMI), smoking, arsenic concentrations in drinking water and blood pressure, dyspnea remained associated with a significant 2.10-fold increased risk of death. When nonsmokers were analyzed separately, dyspnea was associated with a 1.9-fold increased risk of death.

Smoking, male sex, and elevated BMI were also associated with an increased .

"Dyspnea may be a sign of lung disease, heart disease, or a number of other potentially life-threatening conditions," said Dr. Pesola. "Identifying the underlying causes of dyspnea in these individuals might offer an opportunity to reduce the high risk of mortality associated with this condition."

More information: Abstract 49885, Dyspnea As A Predictor Of All-Cause Mortality In Rural Bangladesh: A Population-Based Prospective Study, Scientific Abstract
Category: 01.20 - Occupational and Environmental Respiratory Diseases (EOH), G.R. Pesola1, M. Argos2, F. Parvez3, T. Islam4, A. Ahmed5, M. Rakibuzzaman5, H. Ahsan6; 1Columbia University - New York, NY/US, 2University of Chicago - Chicago/US, 3Columbia University - New York/US, 4University of Chicago in Bangaldesh - Dhaka/BD, 5University of Chicago in Bangladesh - Dhaka/US, 6University of Chicago - Chicago, IL/US

add to favorites email to friend print save as pdf

Related Stories

Dyspnea during daily activities predicts all-cause mortality

Feb 21, 2014

Dyspnea, a sensation of breathlessness, during light daily activities can be used as an indicator of exercise intolerance and low fitness. According to a study on Finnish twins, persistent or developing dyspnea reveals an ...

Chest complaints more costly in obese patients

Mar 08, 2014

(HealthDay)—Higher body mass index (BMI) is associated with increased cost of care and longer hospital stays for patients who present to the emergency department with chest pain and dyspnea, according to ...

Recommended for you

Recorded Ebola deaths top 7,000

9 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

14 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.